by 
Dental membranes and bone graft substitutes are used to support and induce regeneration of alveolar bone and tissues around teeth or dental implants following injury, disease or surgery. Various graft materials including allografts, xenografts, alloplasts and synthetics are used to replace missing bone in dental procedures. Allografts refer to transplants between individuals of the same species while xenografts are transplant from one species to another. Alloplasts are synthetic bone graft composed of calcium sulphate or hydroxyapatite. Significant demand for bone regeneration during various dental procedures like dental implants, socket preservation and ridge augmentation are expected to drive the global dental membrane and bone graft substitute market.
The global dental membrane and bone graft substitute market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Growing elderly population undergoing dental implantation procedures is a key driver for dental membrane and bone graft substitute market. According to World Health Organization, the number of people aged 65 years and above is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050. With advancing age, edentulism and periodontal diseases become highly prevalent which necessitate dental implantation and GBR procedures thereby driving demand for bone graft substitutes.
The significant demand for bone regeneration during various dental implantation and GBR procedures as highlighted in the heading is another major growth driver for this market. Various graft materials are used to regenerate missing or damaged alveolar bone and achieve aesthetics during dental implantation and GBR procedures. This demand for bone graft substitutes to induce proper alveolar bone formation is expected to contribute significantly to the market growth over the forecast period.
Segment Analysis
The global dental membrane and bone graft substitute market is dominated by the dental membrane sub-segment. Dental membranes are in high demand as they provide a protective barrier for bone grafts and facilitate regeneration of lost periodontal tissues. They promote new bone formation by guiding cell migration and differentiation. Other membrane types include collagen membranes, synthetic membranes, and allograft membranes but dental membranes account for over 50% of the market share due to their osteoconductive and osteoinductive properties.
PEST Analysis
Political: Governments across countries are focusing on improving access to dental care through favorable reimbursement policies and dental insurance schemes to reduce disease burden.
Economic: Rising disposable incomes and growing dental tourism in developing nations are supporting market growth. However, high costs of bone grafting procedures can restrain the market.
Social: Increasing awareness about dental health and benefits of dental implants is driving the demand for bone grafting, especially in urban areas. Support from dental associations also aids the market expansion.
Technological: Advancements in membrane and bone graft material properties such as enhanced bioactivity and resorbability are expanding the application scope. Development of stem cell-based graft materials present new opportunities.
Key Takeaways
The global dental membrane and bone graft substitute market size reached US$ 1,045.3 million in 2024 and is expected to witness high growth over the forecast period.
North America currently dominates the market owing to rapidly growing geriatric population, availability of advanced dental care facilities, and favorable reimbursement policies in the US and Canada. Asia Pacific is expected to be the fastest-growing regional market led by China, India, Japan and South Korea on account of improving access to dental services, rising dental tourism and increasing GDP.
Key players operating in the dental membrane and bone graft substitute market are Geistlich Pharma, Zimmer Biomet, Dentsply Sirona, Institut Straumann AG, BioHorizons, Osteogenics Biomedical, Nobel Biocare, and IMPLANT DIRECT.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
